DENNIS HAMP: Open Payments
NPI 1568405397 · WEST JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 108 payments from 33 companies in 2025. Trend: 2023 $2,330 · 2024 $2,239 · 2025 $1,942
Food & beverage: $1,942
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $268 |
| AstraZeneca Pharmaceuticals LP | 5 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $141 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Axsome Therapeutics, Inc. | 8 | $129 |
| Lilly USA, LLC | 8 | $123 |
| Medtronic, Inc. | 5 | $102 |
| PFIZER INC. | 6 | $93 |
| Astellas Pharma US Inc | 4 | $86 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
Products named: QULIPTA, Kerendia, REXULTI, BREZTRI, MINIMED 780G, Veozah, Sunosi, FANAPT.
Industry payments across UT — which companies pay providers there.
